Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Hematology

Staying Safe After CAPS: Prevention and Long-Term Care

At a Glance

After CAPS, long-term safety usually depends on specialist-managed anticoagulation, often warfarin, regular INR monitoring, and a written plan for infections, procedures, and pregnancy. Never change blood-thinner doses without instructions.

Surviving an episode of Catastrophic Antiphospholipid Syndrome (CAPS) is a major milestone, but it also marks the beginning of a new way of managing your health. Because CAPS can recur if the body is triggered, your long-term care focuses on two main goals: keeping your blood at a steady level of “thinness” and acting quickly to stop potential triggers before they spiral out of control.

Pregnancy is also a key consideration: warfarin and DOACs are generally avoided during pregnancy, and people of childbearing potential need early specialist planning for an appropriate heparin/LMWH regimen and coordinated obstetric care.

Understanding Your Triggers

In about 65% of CAPS cases, a specific event acts as a “trigger” that pushes the immune system into a state of widespread clotting [1][2]. Knowing these triggers can help you and your care team stay vigilant:

  • Infection: The most common trigger, involved in roughly 27% to 49% of cases [1][2]. This includes everything from the flu to urinary tract infections.
  • Surgery and Trauma: Any invasive procedure or significant physical injury can provoke a clotting response [2].
  • Medication Changes: Stopping your blood thinners or having “thin” blood that isn’t quite thin enough (subtherapeutic INR) is a major risk factor [2].
  • Pregnancy and Birth: The period during pregnancy and the six weeks following delivery are high-risk windows for CAPS [2][3].
  • Active Lupus: If you also have Systemic Lupus Erythematosus (SLE), a flare of that disease can trigger CAPS [1].

The Gold Standard: Warfarin (VKAs)

While newer blood thinners called DOACs (like rivaroxaban or apixaban) are popular for other conditions, guidelines generally advise against DOACs in triple-positive APS or arterial APS, but the choice and target INR require specialist review [4][5].

Current medical guidelines favor Vitamin K Antagonists (VKAs), such as warfarin, for long-term prevention [4][6]. Warfarin has a long track record of success in preventing the specific types of arterial and venous clots seen in APS. Many patients need prolonged or lifelong anticoagulation [7].

The Danger of the “Gap”

One of the most dangerous times for a CAPS survivor is when anticoagulation is interrupted. Research has shown that a significant number of people who developed CAPS had an INR (a measure of how thin the blood is) below 2.0 at the time of the event [2].

  • Do not stop, restart, double, or change the dose without instructions from your care team. Seek emergency care for severe bleeding, black stools, vomiting blood, severe headache, or head injury.
  • If you miss a dose, contact your anticoagulation clinic or specialist immediately for instructions.
  • Be consistent with vitamin K in your diet, and discuss medication interactions and alcohol use with your care team.

Managing Surgery and Procedures

If you need surgery, a biopsy, or even some dental work, you cannot simply stop your warfarin. You may need bridging therapy, but it is not automatic. The decision depends on thrombotic risk, bleeding risk, and kidney function, so you need an individualized written plan [8][9]. This involves:

  1. Stopping Warfarin: Temporarily pausing your oral medication a few days before the procedure.
  2. Starting Injectables: Using fast-acting, injectable blood thinners (like LMWH or heparin) to keep you protected while the warfarin wears off.
  3. The Restart: Carefully starting your warfarin again as soon as the surgical team determines the risk of bleeding has passed.

Proactive Prevention: Infections and Vaccines

Because infection is such a powerful trigger, preventing illness is a cornerstone of CAPS management.

  • Vaccinations: Stay up to date on all routine vaccines, including flu and pneumonia shots [10].
  • Early Treatment: Contact your clinician for prompt assessment at the first sign of fever or infection; antibiotics should only be used when a clinician identifies a likely bacterial infection, to avoid interactions and side effects [11].
  • Specialist Coordination: Ensure your hematologist and your primary care doctor are in constant communication, especially when you are prescribed new medications or facing a new illness.

Common questions in this guide

Will I need warfarin for life after a CAPS episode?
Many people who have had CAPS need prolonged or lifelong anticoagulation, often with warfarin, a vitamin K antagonist. The duration and target INR, which is a blood-clotting test range, depend on your clotting and bleeding risks, so your specialist should set them.
What should I do if I miss a warfarin dose or my INR is too low?
Do not double the next dose, restart treatment, or change the dose on your own. Contact your anticoagulation clinic or specialist immediately for instructions, because an INR below your prescribed range can reduce protection against clots.
Do I have to stop warfarin before surgery, a biopsy, or dental work?
Do not stop warfarin without an individualized written plan from your care team. Depending on your clotting risk, bleeding risk, and kidney function, you may need a short-acting injectable blood thinner such as LMWH or heparin before and after the procedure.
What blood thinner is safest during pregnancy after CAPS?
Warfarin and newer oral blood thinners called DOACs are generally avoided during pregnancy. If pregnancy is possible or planned, arrange early specialist and obstetric care to choose an appropriate heparin or LMWH regimen.
How can an infection trigger another CAPS episode?
Infection is the most common reported trigger for CAPS, and illnesses such as influenza or a urinary tract infection can be important to address promptly. Call your clinician at the first sign of fever or infection, and use antibiotics only when a clinician identifies a likely bacterial infection.
Which vaccines should I keep up to date after CAPS?
Staying current with routine vaccines, including influenza and pneumonia vaccines, is part of reducing infection risk after CAPS. Ask your care team which vaccines are appropriate and how to time them with your recent treatments.
Which warning signs need emergency help while I am on anticoagulation?
Seek emergency care for severe bleeding, black stools, vomiting blood, a severe headache, or a head injury. Contact your specialist immediately if you develop a new purple rash or sudden confusion.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Catastrophic antiphospholipid syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which organs were most affected during my CAPS episode, and what is the current plan for monitoring their function?
  2. 2.Is there a plan for me to remain on a Vitamin K Antagonist (like warfarin) for life, and what is my target INR range?
  3. 3.If I need surgery or a dental procedure, what is the exact protocol we will use to make sure I am never without protection against clots?
  4. 4.Which vaccinations do I need to stay current on, and when is the best time to get them given my recent treatments?
  5. 5.Who should I call first if I develop a fever or signs of a new infection?
  6. 6.If my INR is consistently out of range, what is causing the INR variability and what specialist-supervised alternatives are appropriate?

References

References (11)
  1. 1

    Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry.

    Rodríguez-Pintó I, Moitinho M, Santacreu I, et al.

    Autoimmunity reviews 2016; (15(12)):1120-1124 doi:10.1016/j.autrev.2016.09.010.

    PMID: 27639837
  2. 2

    Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients.

    Stammler R, Nguyen Y, Yelnik C, et al.

    Journal of thrombosis and haemostasis : JTH 2023; (21(5)):1258-1265 doi:10.1016/j.jtha.2023.02.007.

    PMID: 36792010
  3. 3

    Catastrophic antiphospholipid antibody syndrome presenting as acute vascular occlusion in a young female patient.

    Alonso JV, Del Pozo FJF, Álvarez MV, et al.

    Reumatologia clinica 2018; (14(1)):49-52 doi:10.1016/j.reuma.2016.09.002.

    PMID: 27745843
  4. 4

    EULAR recommendations for the management of antiphospholipid syndrome in adults.

    Tektonidou MG, Andreoli L, Limper M, et al.

    Annals of the rheumatic diseases 2019; (78(10)):1296-1304 doi:10.1136/annrheumdis-2019-215213.

    PMID: 31092409
  5. 5

    Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines.

    Pastori D, Menichelli D, Cammisotto V, Pignatelli P

    Frontiers in cardiovascular medicine 2021; (8()):715878 doi:10.3389/fcvm.2021.715878.

    PMID: 34414220
  6. 6

    Monitoring of anticoagulation in thrombotic antiphospholipid syndrome.

    Cohen H, Efthymiou M, Devreese KMJ

    Journal of thrombosis and haemostasis : JTH 2021; (19(4)):892-908 doi:10.1111/jth.15217.

    PMID: 33325604
  7. 7

    Antiphospholipid Patients Admitted in the Intensive Care Unit: What Must The Rheumatologist Know?

    Moyon Q, Mathian A, Papo M, et al.

    Current rheumatology reports 2024; (26(7)):269-277 doi:10.1007/s11926-024-01148-7.

    PMID: 38652403
  8. 8

    Perioperative management of antithrombotic therapy in patients with thrombotic antiphospholipid syndrome.

    Paquette M, Miranda S, Xu Y, et al.

    Blood advances 2026; (10(9)):3218-3228 doi:10.1182/bloodadvances.2026019610.

    PMID: 41843780
  9. 9

    Perioperative management of patients with antiphospholipid syndrome: a single-center experience.

    Atisha-Fregoso Y, Espejo-Poox E, Carrillo-Maravilla E, et al.

    Rheumatology international 2017; (37(7)):1159-1164 doi:10.1007/s00296-017-3727-0.

    PMID: 28474094
  10. 10

    [2016 review on catastrophic antiphospholipid syndrome].

    Costedoat-Chalumeau N, Coutte L, Le Guern V, et al.

    Presse medicale (Paris, France : 1983) 2016; (45(12 Pt 1)):1084-1092 doi:10.1016/j.lpm.2016.07.023.

    PMID: 27617783
  11. 11

    The catastrophic antiphospholipid syndrome in children.

    Go EJL, O'Neil KM

    Current opinion in rheumatology 2017; (29(5)):516-522 doi:10.1097/BOR.0000000000000426.

    PMID: 28632503

This page is for informational purposes only and does not constitute medical advice. Your hematologist, anticoagulation team, and obstetric specialist should tailor medication, INR, procedure, and pregnancy plans to your situation.